Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for PD L2 (compound)
Most Correlated Studies
- B cells CD80 and PDL2 double and single positive subpopulations
- Melanoma tumor biopsies from patients treated with anti-PD1 therapy
- Macrophages from blood or bone marrow and mesenchymal stem cell-educated macrophages (MEMs)
- Peripheral blood mononuclear cells of old and young adults treated with TLR4, TLR7/8 & RIGI agonists
- Lung tissues of African or European American non-small cell lung cancer patients
Most Relevant Literature
- Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced …
- EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
- Myeloid dendritic cells can kill T cells during chronic hepatitis C virus infection.
- Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expres…
- Programmed death ligand 2 in cancer-induced immune suppression.
Most Relevant Clinical Trials
- Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma
- Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia.
- A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumo…
- Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcino…
- Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Met…
